Molecular Medicine

, Volume 13, Issue 9–10, pp 480–487 | Cite as

Fibrin Gel-Immobilized VEGF and bFGF Efficiently Stimulate Angiogenesis in the AV Loop Model

  • Andreas Arkudas
  • Jimmy Tjiawi
  • Oliver Bleiziffer
  • Lucia Grabinger
  • Elias Polykandriotis
  • Justus P. Beier
  • Michael Stürzl
  • Raymund E. Horch
  • Ulrich Kneser
Research Article


The modulation of angiogenic processes in matrices is of great interest in tissue engineering. We assessed the angiogenic effects of fibrin-immobilized VEGF and bFGF in an arteriovenous loop (AVL) model in 22 AVLs created between the femoral artery and vein in rats. The loops were placed in isolation chambers and were embedded in 500 µL fibrin gel (FG) (group A) or in 500 µL FG loaded with 0.1 ng/µL VEGF and 0.1 ng/µL bFGF (group B). After two and four weeks specimens were explanted and investigated using histological, morphometrical, and ultramorphological [scanning electron microscope (SEM) of vascular corrosion replicas] techniques. In both groups, the AVL induced formation of densely vascularized connective tissue with differentiated and functional vessels inside the fibrin matrix. VEGF and bFGF induced significantly higher absolute and relative vascular density and a faster resorption of the fibrin matrix. SEM analysis in both groups revealed characteristics of an immature vascular bed, with a higher vascular density in group B. VEGF and bFGF efficiently stimulated sprouting of blood vessels in the AVL model. The implantation of vascular carriers into given growth factor-loaded matrix volumes may eventually allow efficient generation of axially vascularized, tissue-engineered composites.



This study was supported by research grants from Xue-Hong and Hans Georg Geis, Baxter Healthcare Corporation, as well as the University of Erlangen (ELAN Program). The authors thank Professor Peter Greil and Mr. Peter Reinhard for production of the Teflon chambers. This work contains parts of Ms. Lucia Grabinger’s doctoral thesis. The authors thank Mr. Tobias Fey for preparation of the SEM specimens. The authors also thank Kristina Heidner and Simon Euler for their technical assistance.


  1. 1.
    Folkman J, Hochberg M. (1973) Self-regulation of growth in three dimensions. J. Exp. Med. 138:745–53.CrossRefGoogle Scholar
  2. 2.
    Kneser U, Kaufmann PM, Fiegel HC, et al. (1999) Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J. Biomed. Mater. Res. 47:494–503.CrossRefGoogle Scholar
  3. 3.
    Goldman E. (1907) The growth of malignant disease in man and the lower animals with special reference to the vascular system. Lancet 2:1236.CrossRefGoogle Scholar
  4. 4.
    Bach AD, Arkudas A, Tjiawi J, et al. (2006) A new approach to tissue engineering of vascularized skeletal muscle. J. Cell. Mol. Med. 10:716–26.CrossRefGoogle Scholar
  5. 5.
    Colton CK. (1995) Implantable biohybrid artificial organs. Cell Transplant 4:415–36.CrossRefGoogle Scholar
  6. 6.
    Cassell OC, Morrison WA, Messina A, et al. (2001) The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue. Ann. N. Y. Acad. Sci. 944:429–42.CrossRefGoogle Scholar
  7. 7.
    Tabata Y. (2003) Tissue regeneration based on growth factor release. Tissue Eng. 9 Suppl 1:S5–15.CrossRefGoogle Scholar
  8. 8.
    Elcin YM, Dixit V, Gitnick G. (2001) Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif. Organs 25:558–65.CrossRefGoogle Scholar
  9. 9.
    Rifkin DB, Moscatelli D. (1989) Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:1–6.CrossRefGoogle Scholar
  10. 10.
    Cornali E, Zietz C, Benelli R, et al. (1996) Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi’s sarcoma. Am. J. Pathol. 149:1851–69.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Banai S, Jaklitsch MT, Shou M, et al. (1994) Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183–9.CrossRefGoogle Scholar
  12. 12.
    Connolly DT, Heuvelman DM, Nelson R, et al. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1470–8.CrossRefGoogle Scholar
  13. 13.
    Ferrara N, Houck K, Jakeman L, Leung DW. (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:18–32.CrossRefGoogle Scholar
  14. 14.
    Langer R, Moses M. (1991) Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J. Cell. Biochem. 45:340–5.CrossRefGoogle Scholar
  15. 15.
    Hashimoto J, Kurosaka M, Yoshiya S, Hirohata K. (1992) Meniscal repair using fibrin sealant and endothelial cell growth factor. An experimental study in dogs. Am. J. Sports Med. 20:537–41.CrossRefGoogle Scholar
  16. 16.
    Albes JM, Klenzner T, Kotzerke J, Thiedemann KU, Schafers HJ, Borst HG. (1994) Improvement of tracheal autograft revascularization by means of fibroblast growth factor. Ann. Thorac. Surg. 57:444–9.CrossRefGoogle Scholar
  17. 17.
    Quirinia A, Viidik A. (1998) The effect of recombinant basic fibroblast growth factor (bFGF) in fibrin adhesive vehicle on the healing of ischaemic and normal incisional skin wounds. Scand. J. Plast. Reconstr. Surg. Hand Surg. 32:9–18.CrossRefGoogle Scholar
  18. 18.
    Nakanishi R, Hashimoto M, Yasumoto K. (1998) Improved airway healing using basic fibroblast growth factor in a canine tracheal autotransplantation model. Ann. Surg. 227:446–54.CrossRefGoogle Scholar
  19. 19.
    Sahni A, Odrljin T, Francis CW. (1998) Binding of basic fibroblast growth factor to fibrinogen and fibrin. J. Biol. Chem. 273:7554–9.CrossRefGoogle Scholar
  20. 20.
    Wong C, Inman E, Spaethe R, Helgerson S. (2003) Fibrin-based biomaterials to deliver human growth factors. Thromb. Haemost. 89: 573–82.CrossRefGoogle Scholar
  21. 21.
    Erol OO, Spira M. (1979) New capillary bed formation with a surgically constructed arteriovenous fistula. Surg. Forum 30:530–1.PubMedGoogle Scholar
  22. 22.
    Hofer SO, Knight KM, Cooper-White JJ, et al. (2003) Increasing the volume of vascularized tissue formation in engineered constructs: an experimental study in rats. Plast. Reconstr. Surg. 111:1186–92.CrossRefGoogle Scholar
  23. 23.
    Kneser U, Polykandriotis E, Ohnolz J, et al. (2006) Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng. 12:1721–31.CrossRefGoogle Scholar
  24. 24.
    Arkudas A, Beier JP, Heidner K, et al. (2007) Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. Tissue Eng. 13:1549–60.CrossRefGoogle Scholar
  25. 25.
    Lametschwandtner A, Lametschwandtner U, Weiger T. (1984) Scanning electron microscopy of vascular corrosion casts—technique and applications. Scan. Electron Microsc. 663–95.Google Scholar
  26. 26.
    Eiselt P, Kim BS, Chacko B, et al. (1998) Development of technologies aiding large-tissue engineering. Biotechnol. Prog. 14:134–40.CrossRefGoogle Scholar
  27. 27.
    Polykandriotis E, Arkudas A, Horch RE, Sturzl M, Kneser U. (2007) Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science. J. Cell. Mol. Med. 11:6–20.CrossRefGoogle Scholar
  28. 28.
    Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267: 26031–7.PubMedGoogle Scholar
  29. 29.
    Lokmic Z, Stillaert F, Morrison WA, Thompson EW, Mitchell GM. (2007) An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J 21:511–22.CrossRefGoogle Scholar
  30. 30.
    Polykandriotis E, Tjiawi J, Euler S, et al. (2007) The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc. Res. 2007 Apr. 18 [Epub ahead of print].Google Scholar
  31. 31.
    Dvorak HF, Brown LF, Detmar M, Dvorak AM. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146: 1029–39.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Ye Q, Zund G, Benedikt P, et al. (2000) Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 17: 587–91.CrossRefGoogle Scholar
  33. 33.
    Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U. (2007) Gene transfer strategies in tissue engineering. J. Cell. Mol. Med. 11:206–23.CrossRefGoogle Scholar
  34. 34.
    Kneser U, Schaefer DJ, Polykandriotis E, Horch RE. (2006) Tissue engineering of bone: the reconstructive surgeon’s point of view. J. Cell. Mol. Med. 10:7–19.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2007

Authors and Affiliations

  • Andreas Arkudas
    • 1
  • Jimmy Tjiawi
    • 1
  • Oliver Bleiziffer
    • 1
  • Lucia Grabinger
    • 1
  • Elias Polykandriotis
    • 1
  • Justus P. Beier
    • 1
  • Michael Stürzl
    • 2
  • Raymund E. Horch
    • 1
  • Ulrich Kneser
    • 1
  1. 1.Department of Plastic and Hand SurgeryUniversity of Erlangen Medical CenterErlangenGermany
  2. 2.Department of Molecular and Experimental SurgeryUniversity of Erlangen Medical CenterErlangenGermany

Personalised recommendations